Skip to Main Content

Author Details

Alfonso Urbanucci
Northwestern University Feinberg School of Medicine Chicago
2008
39
23
PMIDPaper TitleJournal TitlePublished Year
36865297Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients.medRxiv2023
36798177Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial.Res Sq2023
34972988Measuring Autophagic Cargo Flux with Keima-Based Probes.Methods Mol Biol2022
35697807Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.Nat Biotechnol2022
34283056Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response.Cancers (Basel)2021
33925994Gene Regulation Network Analysis on Human Prostate Orthografts Highlights a Potential Role for the <i>JMJD6</i> Regulon in Clinical Prostate Cancer.Cancers (Basel)2021
33922147The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology.J Pers Med2021
34489465Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse.Nat Commun2021
32555329AR and ERG drive the expression of prostate cancer specific long noncoding RNAs.Oncogene2020
32605315Dysregulation of MITF Leads to Transformation in MC1R-Defective Melanocytes.Cancers (Basel)2020
32611550Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9.Mol Cancer Res2020
32365348Loss of Snord116 impacts lateral hypothalamus, sleep, and food-related behaviors.JCI Insight2020
30844748Chromatin reprogramming as an adaptation mechanism in advanced prostate cancer.Endocr Relat Cancer2019
31551480Drivers of AR indifferent anti-androgen resistance in prostate cancer cells.Sci Rep2019
31395667The β<sub>2</sub>-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells.Mol Cancer Res2019
31149037High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.Theranostics2019
28624514Bromodomain-containing proteins in prostate cancer.Mol Cell Endocrinol2018
30537516Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.Cancer Cell2018
27669432Cell cycle-coupled expansion of AR activity promotes cancer progression.Oncogene2017
28415728Lipid degradation promotes prostate cancer cell survival.Oncotarget2017
28412251c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.EBioMedicine2017
28359301Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.BMC Genomics2017
29269934The expression of AURKA is androgen regulated in castration-resistant prostate cancer.Sci Rep2017
28591577Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.Cell Rep2017
27252783Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells.Epigenetics Chromatin2016
27638884CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions.Nucleic Acids Res2016
25965834CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.Oncotarget2015
25869206Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer.Oncotarget2015
25860483Slug-dependent upregulation of L1CAM is responsible for the increased invasion potential of pancreatic cancer cells following long-term 5-FU treatment.PLoS One2015
24497572Androgen-regulated metabolism and biosynthesis in prostate cancer.Endocr Relat Cancer2014
22674191Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.Prostate2013
21909140Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.Oncogene2012
22245783Androgen receptor (AR) aberrations in castration-resistant prostate cancer.Mol Cell Endocrinol2012
22212979Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure.Prostate2012
22266859Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.Oncogene2012
22431170Chemical castration and anti-androgens induce differential gene expression in prostate cancer.J Pathol2012
20945501Androgen regulation of micro-RNAs in prostate cancer.Prostate2011
19720414Potential internalisation of caliciviruses in lettuce.Int J Food Microbiol2009
18673534Androgen regulation of the androgen receptor coregulators.BMC Cancer2008
  • 1 - 39 of 39

Recommended Authors

Joshua Urrutia
Knight Cancer Institute, Oregon Health & Science University (OHSU)
Career Start Year 2016
Number of shared co-authors 5
Wanting Han
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Career Start Year 2016
Number of shared co-authors 8
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 7
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 6
Shuai Gao
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Career Start Year 2012
Number of shared co-authors 10
Ren?? B??ttcher
Universitat Pompeu Fabra
Career Start Year 2012
Number of shared co-authors 7
Haiyang Guo
the Second Hospital, Cheeloo College of Medicine, Shandong University
Career Start Year 2011
Number of shared co-authors 12
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Career Start Year 2010
Number of shared co-authors 28
Alastair Davies
University of British Columbia
Career Start Year 2008
Number of shared co-authors 4
Ram S Mani
UT Southwestern Medical Center
Career Start Year 2008
Number of shared co-authors 7
Changmeng Cai
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Career Start Year 2006
Number of shared co-authors 11
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 6
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 24
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 2
Wilbert Zwart
Oncode Institute, The Netherlands Cancer Institute
Career Start Year 2004
Number of shared co-authors 20
Gong-Hong Wei
Fudan University Shanghai Cancer
Career Start Year 2004
Number of shared co-authors 6
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 20
Adam Sharp
The Institute for Cancer Research
Career Start Year 2003
Number of shared co-authors 5
Luke A Selth
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 13
David S Rickman
Meyer Cancer Center
Career Start Year 2001
Number of shared co-authors 5
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Nadia Boufaied
Research Institute of the McGill University Health Centre
Career Start Year 2000
Number of shared co-authors 13
Amina Zoubeidi
University of British Columbia
Career Start Year 2000
Number of shared co-authors 24
Yuzhuo Wang
University of British Columbia
Career Start Year 2000
Number of shared co-authors 22
Joshi J Alumkal
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 14
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 12
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 11
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 32
Gyorgy Petrovics
Henry Jackson Foundation for the Advancement of Military Medicine (HJF)
Career Start Year 1990
Number of shared co-authors 10
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 26

Collaborators

Ian G Mills
Queen's University Belfast
Co-authored papers 15
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 14
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 8
Leena Latonen
Foundation for the Finnish Cancer Institute
Co-authored papers 5
Elai Davicioni
Veracyte Inc.
Co-authored papers 4
Sinja Taavitsainen
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 3
Nikolai Engedal
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 3
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 3
Guido Jenster
Erasmus University Medical Center
Co-authored papers 3
Eivind Hovig
Center for Bioinformatics, University of Oslo
Co-authored papers 3
Gerhardt Attard
The Institute of Cancer Research
Co-authored papers 3
Shaolong Cao
the University of Texas MD Anderson Cancer Center
Co-authored papers 2
Thorsten Schlomm
Charite - University Hospital Berlin
Co-authored papers 2
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 2
Eva Corey
University of Washington School of Medicine
Co-authored papers 2
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 2
Mandeep Takhar
GenomeDx Biosciences Inc.
Co-authored papers 2
Nicholas Erho
GenomeDx Biosciences Inc.
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
Matti Annala
University of British Columbia
Co-authored papers 2
Ladan Fazli
University of British Columbia
Co-authored papers 2
Sigve Nakken
University of Oslo
Co-authored papers 2
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 2
Vyacheslav Amstislavskiy
Max-Planck-Institute for Molecular Genetics
Co-authored papers 1
S??ren Matzk
Max Planck Institute for Molecular Genetics
Co-authored papers 1
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 1
Shuangxi Ji
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Wenyi Wang
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Yaoyi Dai
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Vinayak Bhandari
University of Toronto
Co-authored papers 1
Release 1.2